Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Brain Metastases
Interventions: DRUG: Pembrolizumab
Sponsor: Weill Medical College of Cornell University
Collaborators: Merck Sharp & Dohme LLC